MARKET

BNTX

BNTX

BIONTECH
NASDAQ

Real-time Quotes | Nasdaq Last Sale

70.36
+4.75
+7.24%
Pre Market: 74.00 +3.64 +5.17% 07:18 07/13 EDT
OPEN
67.00
PREV CLOSE
65.61
HIGH
71.29
LOW
67.00
VOLUME
2.87M
TURNOVER
--
52 WEEK HIGH
105.00
52 WEEK LOW
12.53
MARKET CAP
16.08B
P/E (TTM)
-73.8378
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 9 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BNTX stock price target is 48.72 with a high estimate of 71.43 and a low estimate of 28.17.

EPS

BNTX News

More
'Head Above Water': Stock Market Update For The Week Ahead
The Past Week, In A Nutshell
Benzinga · 14h ago
2 Healthcare IPOs Getting a Tailwind From COVID-19 to Consider Buying
Motley Fool · 17h ago
3 Top Healthcare Stocks to Buy Right Now
Motley Fool · 1d ago
Bill Gates warns against coronavirus vaccine going to highest bidder — 'We'll have a deadlier pandemic'
As countries and companies race to bring a Covid-19 vaccine to the market, concerns have risen about wealthier nations receiving more drugs than developing countries.
CNBC.com · 1d ago
Atlanta Mayor Says City Will Roll Back to Phase 1 of Reopening
Barrons.com · 2d ago
Here's what happened to the stock market on Friday
Stocks got a jolt Friday as news about a potential coronavirus treatment increased hope for an economic recovery following the outbreak.
CNBC.com · 2d ago
Pfizer and BioNTech's Coronavirus Vaccine Ready for Regulatory Submission in December, Maybe Earlier
Motley Fool · 2d ago
BioNTech to Seek Covid-Vaccine Regulatory Clearance in 2020
TheStreet.com · 2d ago

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About BNTX

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
More

Webull offers kinds of BioNTech SE - ADR stock information, including NASDAQ:BNTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNTX stock methods without spending real money on the virtual paper trading platform.